India, July 21 -- Indian shares are seen opening on a cautious note on Wednesday as investors weigh geopolitical and trade tensions against positive global cues.
Pharma stocks could be in focus after U.S. President Donald Trump announced a phased tariff plan on imported generic medicines.
Under the proposal, generic drugs imported into the U.S. will continue to face zero tariffs until August 2028, after which duties will increase to 100 percent and then 200 percent, to incentivize U.S. manufacturing.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....